A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Fruquintinib
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Sponsors Criterium
Most Recent Events
- 03 Jun 2025 New trial record